Congress 2014 has ended
Back To Schedule
Friday, May 2 • 12:45pm - 1:45pm
A Targeted Therapy for First-Line Treatment of Chronic Lymphocytic Leukemia

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

This theater presentation will review the efficacy and safety of GAZYVA in combination with chlorambucil as shown in CLL11; explore the proposed mechanism of action of GAZYVA; and review the dosing and administration of GAZYVA in previously untreated patients with chronic lymphocytic leukemia. 

A Genentech promotional activity in conjunction with ONS:Edge, Inc., a subsidiary of ONS.

This event qualifies for the ONS:Edge Unlock the Levels of Learning contest. Seating is on a first-come, first-served basis. Please plan to arrive early to have the best chance at securing your seat. 

Friday May 2, 2014 12:45pm - 1:45pm PDT
Theater 2, Hall B Anaheim Convention Center, 800 W. Katella Ave, Anaheim, CA 92802
  Industry Event
  • CNE Status No CNE
  • Contact Hours of CNE: N/A

Attendees (0)